SCHEMBL29564526

SCHEMBL29564526

Cc1cccc(NC(=O)c2cc(Br)ccc2C(=O)O)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SORT1 Q99523 18/20 1.00
▸ GRM5 P41594 1/20 0.64
▸ ALDH1A1 P00352 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15903096 1.00 SORT1 (1.00) SORT1GRM5ALDH1A1HPGDHSD17B10
SCHEMBL15903094 0.95 SORT1 (1.00) SORT1
SCHEMBL29564231 0.95 SORT1 (1.00) SORT1
SCHEMBL20610068 0.86 SORT1 (0.76) SORT1GRM5ALDH1A1HPGDHSD17B10
SCHEMBL29981174 0.86 SORT1 (0.90) SORT1GRM5ALDH1A1HPGDHSD17B10
SCHEMBL30415774 0.86 SORT1 (0.76) SORT1GRM5ALDH1A1HPGDHSD17B10
SCHEMBL15903424 0.86 SORT1 (0.90) SORT1GRM5ALDH1A1HPGDHSD17B10
SCHEMBL15903683 0.84 SORT1 (0.90) SORT1GRM5ALDH1A1
SCHEMBL29981587 0.84 SORT1 (0.90) SORT1GRM5ALDH1A1
SCHEMBL15903313 0.84 SORT1 (0.90) SORT1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116194096-A Sortilin antagonists for preventing and treating hearing impairment 因苏森斯有限公司 2023-05-30 — — CN claimed
CN-115297856-A Sortilin antagonists for the treatment of diabetic retinopathy 舒感有限公司 2022-11-04 — — CN claimed
EP-4225280-A1 A SORTILIN ANTAGONIST FOR USE IN THE PREVENTION OR TREATMENT OF HEARING LOSS Insusense ApS (DK) 2023-08-16 — — EP disclosed
CN-116194096-A Sortilin antagonists for preventing and treating hearing impairment 因苏森斯有限公司 2023-05-30 — — CN disclosed
EP-4121033-A1 SORTILIN ANTAGONISTS FOR USE IN THE TREATMENT OF DIABETIC RETINOPATHY Insusense ApS (DK) 2023-01-25 — — EP disclosed
CN-115297856-A Sortilin antagonists for the treatment of diabetic retinopathy 舒感有限公司 2022-11-04 — — CN disclosed
WO-2022074119-A1 A SORTILIN ANTAGONIST FOR USE IN THE PREVENTION OR TREATMENT OF HEARING LOSS INSUSENSE ApS (DK) 2022-04-14 — — WO disclosed
Send feedback